K102-Env was detected in 34.00% of patients with PDAC (n = 100), 39% of patients with HCC (n = 100), and 28.0% of patients with NSCLC (n = 100), whereas only 5.0% of healthy individuals (n = 100) had marginally increased HERV-K102 (Figure 3B). The gene discussed is ERVW-1; the disease is hepatocellular carcinoma.